rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2010-5-13
|
pubmed:abstractText |
Recent evidence suggests that nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma. We tested this hypothesis in an independent large series from a single institution.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1527-3792
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
183
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2143-7
|
pubmed:dateRevised |
2010-12-27
|
pubmed:meshHeading |
pubmed-meshheading:20399450-Carcinoma, Renal Cell,
pubmed-meshheading:20399450-Cell Nucleolus,
pubmed-meshheading:20399450-Female,
pubmed-meshheading:20399450-Humans,
pubmed-meshheading:20399450-Kidney Neoplasms,
pubmed-meshheading:20399450-Male,
pubmed-meshheading:20399450-Middle Aged,
pubmed-meshheading:20399450-Predictive Value of Tests,
pubmed-meshheading:20399450-Prognosis,
pubmed-meshheading:20399450-Reproducibility of Results
|
pubmed:year |
2010
|
pubmed:articleTitle |
Fuhrman grade provides higher prognostic accuracy than nucleolar grade for papillary renal cell carcinoma.
|
pubmed:affiliation |
Department of Urology, University of California-Los Angeles, Los Angeles, California 90025-1738, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|